Yahoo! Finance: Dialectic Therapeutics Receives FDA Clearance of IND Application for Lead Antiapoptotic Protein Targeted Degradation (APTaD) Candidate DT2216

March 3, 2021

Robert Hromas, MD, FACP, dean of the Joe R. and Teresa Lazano Long School of Medicine, is mentioned in this Yahoo! Finance story about Dialectic Therapeutics, Inc., a Dallas-based biotechnology company focused on creating innovative new technologies to treat cancer. Dialectic has research partners and facilities at UT Health San Antonio and University of Florida […]




KSAT 12: KSAT Community spotlight: SA Cancer Council

March 2, 2021

The SA Cancer Council, an all-volunteer nonprofit organization that supports the Mays Cancer Center, home to UT Health San Antonio MD Anderson, was put in the KSAT 12 Community spotlight for its donation of more than $5.6 million to the center, even as we are still going through unprecedented times with the coronavirus. Watch the […]